First Financial Corp’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-117
Closed -$2.33K 474
2024
Q1
$2.33K Buy
+117
New +$2.26K ﹤0.01% 501
2018
Q2
Sell
-250
Closed -$12K 340
2018
Q1
$12K Hold
250
0.01% 303
2017
Q4
$12K Hold
250
0.01% 323
2017
Q3
$11K Sell
250
-53
-17% -$2.26K 0.01% 335
2017
Q2
$12K Hold
303
0.01% 340
2017
Q1
$12K Buy
303
+250
+472% +$9.74K 0.01% 346
2016
Q4
$2K Hold
53
﹤0.01% 383
2016
Q3
$2K Sell
53
-50
-49% -$1.75K ﹤0.01% 395
2016
Q2
$3K Hold
103
﹤0.01% 422
2016
Q1
$3K Hold
103
﹤0.01% 429
2015
Q4
$4K Hold
103
﹤0.01% 423
2015
Q3
$3K Buy
103
+50
+94% +$1.74K ﹤0.01% 429
2015
Q2
$2K Hold
53
﹤0.01% 459
2015
Q1
$3K Sell
53
-156
-75% -$7.23K ﹤0.01% 443
2014
Q4
$10K Buy
+209
New +$8.21K 0.01% 410

Other funds holding AVNS

First Financial Corp's AVNS Position: Q2 2024 in Review

First Financial Corp sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 117 shares — an estimated $2.33K sold.

First Financial Corp first reported a position in AVNS in Q4 2014 and held it in 15 quarters. The position peaked at $12K in Q1 2018. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • First Financial Corp reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • First Financial Corp sold 117 Avanos Medical shares in Q2 2024, an estimated $2.33K.
  • First Financial Corp first reported a position in Avanos Medical in Q4 2014 and held it in 15 quarters.
  • First Financial Corp's Avanos Medical position peaked at $12K in Q1 2018.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on First Financial Corp's 13F filing for Q2 2024, filed 11 Jul 2024.